Live stream preview
Cellares CEO on $380M collaboration with Bristol Myers Squibb and its impact
Floor Talk
•
6m 18s
Cellares and Bristol Myers Squibb have entered a $380M collaboration to enhance the manufacturing of CAR T cell therapies.
Cellares Co-Founder & CEO Fabian Gerlinghaus talks about the terms of the agreement, its impact and future partnership plans on #NYSEFloorTalk with Judy Khan Shaw.
Up Next in Floor Talk
-
Stephen Silver Fine Jewelry Founder S...
-
Nuvemshop Co-Founder & CEO Santiago S...
About Nuvemshop:
Nuvemshop is a developer of an e-commerce platform designed for SMEs and entrepreneurs to sell products and services online. The company's platform offers product management, sales automation, integrations, and agreements to make shipments, enabling businesses to create and deve...
-
Hear Entière Founding Medical Directo...
Dr. Melissa K. Levin, Founding Medical Director of Entière Dermatology, joins Kristen Scholer on NYSE Floor Talk
